Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linise is a South Korean medical aesthetics company specializing in the development and manufacturing of advanced dermal fillers and skin rejuvenation products. The company's flagship product line includes hyaluronic acid-based fillers designed for various aesthetic applications, utilizing proprietary Multi-staged Cross-linking Technology (MCT) to ensure safety, high viscoelasticity, and longevity. In addition to fillers, Linise offers PDO (polydioxanone) lifting threads and other professional skincare solutions for the global aesthetic market. The company focuses on providing high-quality, CE-certified products to practitioners in the dermatology and plastic surgery fields, with a strong presence in international markets including Europe and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LINISE.